2026 China Healthcare Decision-Makers Conference (CHDC)
Every step forward in corporate competitiveness begins with the judgment and leadership of decision-makers. From target selection and technology platform choices to product portfolio decisions, clinical development strategies, BD transactions, market…
2026 H2 AbbVie China Partnering Day
In 2026, cross-border licensing transactions for innovative drugs in China continued to heat up, and multinational pharmaceutical companies accelerated their efforts to expand their local innovation in China. Recently, AbbVie, a global research-based…
2026 Global XDC Innovation Conference
Explore the new frontiers of XDC fusion and breakthrough innovation – under the theme: Convergence & Innovation: The New Frontiers of Bioconjugation. Highlights Sneak Peek🔹 Focused Innovation Agenda – Key XDC technologies and emerging modalities,…
CPHI & PMEC Shenzhen 2026
China is the world’s 2nd largest pharma market, which is valued at USD 282.07bn in 2024, and projected to reach USD 402bn by 2029. AI in pharma is surging at 41.52% CAGR, the fastest across all sectors. Why Shenzhen? Shenzhen’s 1,300+ biotech…
Clinical Trial Supply China 2026
Clinical Trial Supply China is returning for a second year! This is your gateway to understanding and excelling in the rapidly evolving landscape of clinical trial logistics in China. Why attend? Navigate Local Challenges: Gain critical insights into the…
CBI 2026 – Antibody Drug Development Conference
Bispecific antibody deal volumes continue to hit record highs, as the battlefield for antibody therapeutics rapidly expands from oncology into multi-billion-dollar markets such as autoimmune diseases, chronic conditions, and cardiovascular disorders.…
CBI 2026 – XDC Drug Development Conference
Currently, antibody-drug conjugates (ADCs) have entered a critical phase characterized by intensive clinical advancement and commercialization. Meanwhile, emerging technological platforms such as peptide-drug conjugates (PDCs) and radionuclide-conjugated…
China Medicine Connect Expo 2026
China Medicine Connect Expo 2026 is a large pharmaceutical/biotech industry event covering innovative drugs, biologics, CGT, ADC/XDC, peptides, CMC, manufacturing and partnering. Organizers expect 800+ pharma companies and substantial…
BIC 2026 8th Asia Biologics Innovation ConferenceÂ
BIC 2026 will showcase next-generation modalities—from ADCs and siRNA to iPSCs and peptides—to advance drug R&D and clinical progress in cardiorenal, metabolic, and liver diseases. A key focus will be placed on pioneering strategies that transition…